Schiesl Andrew R

Schiesl sold 18,000 IR shares at $98.00 on 2026-02-17; post-sale holdings reduced 61.2% to 11,405 shares

Andrew R. Schiesl sold 18,000 shares (61.2% reduction) at $98.00, near the 52-week high of $98.76, after a 30-day run of +13.0% and 90-day gain of +22.5%. His same-ticker history at Ingersoll Rand shows 5 prior sells with mixed outcomes: 2 of 5 were well-timed (negative 90-day returns post-sale), while 3 produced gains after he sold, suggesting inconsistent sell timing. The cross-ticker track record shows a 50.00% well-timed rate on 6 prior sells with an average 90-day return of +3.7%, indicating modest success timing sales overall. At a P/E of 130.00 against $244.1M net income on $2.0B quarterly revenue, the valuation is stretched relative to earnings.

Schiesl sells 13,228 IR shares at $87.05; holdings drop -30% to 30.8K shares as stock falls -17.6% from 52-week high

Schiesl Andrew R sold 13,228 shares of Ingersoll Rand on 2025-02-18 for $1,151,497.40, reducing his stake by 30% to 30,846 post-transaction shares. The sale occurred at $87.05, and the stock has since declined to $86.77 (current price), having fallen -16.6% over 90 days and -17.6% from its 52-week high of $105.35. Examining his same-ticker history at IR, Schiesl's 5 prior sales show mixed timing: his 2024-11-05 sale was followed by a +8.3% 30-day gain, while three of his other IR sales preceded negative 90-day returns. His cross-ticker track record shows a 40% well-timed rate on sells (negative 90-day returns), which is modest. The current transaction's significance is tempered by the stock's already-depressed valuation relative to recent highs and the insider's mixed historical accuracy at timing this specific ticker.

Andrew R Schiesl sold 24,234 shares of Ingersoll Rand (IR) for $2.3M at $95.08 on 2024-11-05, reducing stake 44.0% to 30.8K shares.

Schiesl executed a substantial reduction in his Ingersoll Rand position, divesting 24,234 shares (-44.0% of prior holdings) at $95.08, well below the current price of $103.53 and below the 52-week high of $103.53. His prior sell transactions at IR show mixed timing outcomes: three of his four prior sales at this ticker were followed by net 90-day gains (the stock rose post-sale), while one sale on 2024-05-17 was followed by neutral 90-day performance. Only 1 of his 4 prior IR sales achieved negative 90-day returns, suggesting his sales at this ticker have not been consistently well-timed. The company's fundamentals appear robust, with annual revenue growth of +16.2% and a recent quarterly revenue of $1,861,000,000.00, though the P/E of 49.77 reflects a premium valuation. This sale represents a significant structural reduction rather than a routine portfolio adjustment, and the timing relative to the stock's subsequent 4.7% 30-day appreciation and current proximity to 52-week highs warrants investor attention.

Schiesl sells 24,021 shares at blended $90.05, reducing IR stake 43.8%; stock now off 12.1% from 52-week high.

Andrew R. Schiesl completed 2 separate sales totaling 24,021 shares for $2,163,074.94 on August 8–9, 2024, reducing his holdings from 54,867 to 30,846 shares (a -43.8% reduction). The blended average sale price of $90.05 exceeds the current price of $88.26, indicating the stock has declined since execution. IR stock is currently -12.1% from its 52-week high and -9.3% over the past 30 days. Schiesl's prior 2 sales at IR showed mixed timing: his May 17 sale was followed by a -0.8% 30-day return, while his March 11 sale posted a +4.0% 30-day return but a -0.4% 90-day return. At the 90-day measurement point across his same-ticker history, 1 of 1 prior sells was well-timed. His cross-ticker track record shows 100.00% well-timed rate on 2 prior sells, though this represents limited activity and does not necessarily predict accuracy on this specific transaction.